CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 180, Issue 1-2, 2006, Pages 178-184

  Kumar, Manoj ^a   Putzki, Norman ^b   Limmroth, Volker ^b   Remus, Ralph ^a   Lindemann, Monika ^a   Knop, Dietmar ^c   Mueller, Norbert ^c   Hardt, Cornelia ^a   Kreuzfelder, Ernst ^a   Grosse Wilde, Hans ^a  

^a Institut fuer Immunologie   (Germany)

^b MS Zentrum Essen Klinik fuer Neurologie   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

FOXP3; Multiple sclerosis; Myelin basic protein; Proliferation; Regulatory T cells

Indexed keywords

MYELIN BASIC PROTEIN; POKEWEED MITOGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 33751113922     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.08.003     Document Type: Article

References (24)

1. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 167 (2001) 1245-1253
2. Cosmi L., Liotta F., Lazzeri E., Francalanci M., Angeli R., Mazzinghi B., Santarlasci V., Manetti R., Vanini V., Romagnani P., Maggi E., Romagnani S., and Annunziato F. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102 (2003) 4107-4114
3. Davies S., Nicholson T., Laura M., Giovannoni G., and Altmann D.M. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 371-377
4. Ditschkowski M., Kreuzfelder E., Rebmann V., Ferencik S., Majetschak M., Schmid E.N., Obertacke U., Hirche H., Schade U.F., and Grosse-Wilde H. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann. Surg. 229 (1999) 246-254
5. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P.H., Suri-Payer E., and Wildemann B. Reduced suppressive effect of CD4+CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343-3352
6. Hong J., Zang Y.C., Li S., Rivera V.M., and Zhang J.Z. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur. J. Immunol. 34 (2004) 870-881
7. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81 (2005) 45-52
8. Jarvis L.B., Matyszak M.K., Duggleby R.C., Goodall J.C., Hall F.C., and Gaston J.S. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. Eur. J. Immunol. 35 (2005) 2896-2908
9. Khoury S.J., Guttmann C.R., Orav E.J., Kikinis R., Jolesz F.A., and Weiner H.L. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch. Neurol. 57 (2000) 1183-1189
10. Lassmann H., Bruck W., and Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7 (2001) 115-121
11. Lunemann J.D., Ruckert S., Kern F., Wendling U., van der Zee R., Volk H.D., and Zipp F. Cross-sectional and longitudinal analysis of myelin-reactive T cells in patients with multiple sclerosis. J. Neurol. 251 (2004) 1111-1120
12. Limmroth, V., Putzki, N., Bertelmann, M., Kachuck, N., Interferon Beta for the Treatment of Relapsing Multiple Sclerosis: A Review of Head-to-Head Trials. Exp Rev Neurotherapeutics in press.
13. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2 (2001) 816-822
14. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
15. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
16. Putheti P., Pettersson A., Soderstrom M., Link H., and Huang Y.M. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24 (2004) 155-161
17. Raine C.S., and Cross A.H. Axonal dystrophy as a consequence of long-term demyelination. Lab. Invest. 60 (1989) 714-725
18. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
19. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161 (1985) 72-87
20. Stephens L.A., Gray D., and Anderton S.M. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17418-17423
21. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
22. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
23. Wing K., Lindgren S., Kollberg G., Lundgren A., Harris R.A., Rudin A., Lundin S., and Suri-Payer E. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur. J. Immunol. 33 (2003) 579-587
24. Wing K., Fehervari Z., and Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int. Immunol. 18 (2006) 991-1000